Related Experiment Video
Updated: Nov 1, 2025

05:30
Laparoscopic Anatomical Right Hemihepatectomy via the In Situ Anterior Approach
Published on: August 8, 2025
186
How we approach hemangiomas in infants
Jennifer L R Mayer1, Stefanos Intzes2, Vikash S Oza3
1Vascular Anomalies and Birthmarks Program, Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida, USA.
Pediatric Blood & Cancer
|June 21, 2021
Summary
Pediatric oncologists manage complex benign vascular tumors like hemangiomas, which are diverse and require tailored treatment. Vigilance for rare malignant mimics is crucial for effective patient care.
Area of Science:
- Oncology
- Vascular Biology
- Pediatric Medicine
Background:
- Benign vascular tumors, particularly hemangiomas, are common referrals to specialized clinics.
- Contemporary research highlights the heterogeneity of hemangiomas, challenging a singular definition.
- These tumors exhibit diverse natural histories, growth patterns, and therapeutic responses.
Purpose of the Study:
- To outline the evaluation and management strategies for complex benign vascular tumors in children.
- To address the life-threatening complications associated with these vascular anomalies.
- To emphasize the importance of differentiating benign tumors from malignant mimics.
Main Methods:
- Review of current literature on pediatric vascular tumors.
- Clinical case examples illustrating diagnostic and therapeutic approaches.
- Discussion of differential diagnoses, including soft tissue sarcomas and congenital leukemia.
Main Results:
- Hemangiomas represent a spectrum of related vascular tumors, not a single entity.
- Effective management requires understanding individual tumor characteristics and potential complications.
- Distinguishing benign from malignant conditions is critical for appropriate treatment.
Conclusions:
- Pediatric oncologists play a vital role in managing diverse benign vascular tumors.
- A comprehensive approach is necessary to address tumor complexity, complications, and syndromes.
- Awareness of malignant hemangioma mimickers is essential for accurate diagnosis and treatment.
More Related Videos
Related Concept Videos
Development of Blood Vessels
980
The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
980
Mechanism of Angiogenesis
6.2K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.2K
Regulation of Angiogenesis and Blood Supply
3.0K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K

